3B BlackBio DX Stock Screener | Share Price & Fundamental Analysis
3BBLACKBIO
Healthcare Service Provider
Share Price BSE
₹1612.10
▲
38.80 (2.47%)
Track 3B BlackBio DX share price live with TickJournal's free stock screener.
Analyze 3B BlackBio DX share price history trends and compare 52-week high low
levels.
Calculate 3BBLACKBIO stock fair value using fundamental analysis and view live share price charts.
Determine 3B BlackBio DX share intrinsic value and compare it with current 3BBLACKBIO share price.
Record your 3B BlackBio DX trades in TickJournal's free trading journal and track your portfolio performance.
3B BlackBio DX Market Cap
₹1,367.82 Cr.
EPS (TTM)
₹55.66
Dividend Yield
0.24%
Debt to Equity
-
3BBLACKBIO 52 Week High
₹1970.20
3B BlackBio DX 52 Week Low
₹1182.30
Operating Margin
35.00%
Profit Margin
29.63%
3BBLACKBIO Revenue (TTM)
₹27.00
EBITDA
₹13.00
Net Income
₹8.00
Total Assets
₹296.00
Total Equity
₹271.00
3B BlackBio DX Share Price History - Stock Screener Chart
Screen 3BBLACKBIO historical share price movements with interactive charts. Analyze price trends and patterns.
3B BlackBio DX Company Profile - Fundamental Screener
Screen 3B BlackBio DX company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for 3BBLACKBIO shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE994E01018
3B BlackBio DX Balance Sheet Screener
Screen 3BBLACKBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 296 | 248 | 214 | 192 | 194 | 45 | 36 | 30 | 26 | 24 |
| Current Assets | 132 | 123 | 114 | 82 | 118 | 39 | 32 | 26 | 22 | 21 |
| Fixed Assets | 7 | 7 | 8 | 7 | 5 | 4 | 4 | 4 | 3 | 3 |
| Liabilities | ||||||||||
| Total Liabilities | 296 | 248 | 214 | 192 | 194 | 45 | 36 | 30 | 26 | 24 |
| Current Liabilities | 6 | 5 | 4 | 3 | 2 | 2 | 3 | 3 | 4 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 271 | 226 | 196 | 172 | 148 | 34 | 23 | 19 | 11 | 10 |
| Share Capital | 9 | 9 | 9 | 8 | 8 | 8 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 260 | 215 | 185 | 146 | 125 | 25 | 16 | 12 | 5 | 4 |
3B BlackBio DX Income Statement Screener - Profit & Revenue Analysis
Screen 3B BlackBio DX income statement and profit fundamentals.
Analyze 3BBLACKBIO quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for 3B BlackBio DX share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27 | 27 | 39 | 56 | 27 | 23 | 33 | 28 | 19 | 17 | 22 | 20 | 20 | 13 | 19 |
| Expenses | 15 | 10 | 19 | 29 | 13 | 9 | 13 | 10 | 11 | 8 | 11 | 9 | 13 | 7 | 8 |
| EBITDA | 13 | 16 | 20 | 27 | 14 | 15 | 20 | 18 | 9 | 9 | 11 | 12 | 8 | 6 | 11 |
| Operating Profit % | 35.00% | 53.00% | 43.00% | 43.00% | 43.00% | 56.00% | 56.00% | 59.00% | 41.00% | 45.00% | 41.00% | 50.00% | 32.00% | 44.00% | 53.00% |
| Depreciation | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 13 | 16 | 20 | 27 | 14 | 14 | 19 | 18 | 8 | 9 | 10 | 11 | 8 | 6 | 11 |
| Tax | 5 | 3 | 5 | 4 | 5 | 3 | 4 | 4 | 3 | 2 | 3 | 3 | 3 | 2 | 3 |
| Net Profit | 8 | 13 | 15 | 22 | 9 | 11 | 15 | 14 | 5 | 7 | 8 | 9 | 5 | 5 | 8 |
| EPS | 9.38 | 14.76 | 17.55 | 26.19 | 10.26 | 13.19 | 17.35 | 15.75 | 6.94 | 8.41 | 8.86 | 9.94 | 6.43 | 6.28 | 9.70 |
3B BlackBio DX Cash Flow Screener - Liquidity Fundamentals
Screen 3BBLACKBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 43 | 27 | 20 | 37 | 98 | 7 | 4 | 2 | 1 | 1 |
| Investing Activities | -34 | -20 | 15 | -28 | -70 | -1 | -1 | -1 | 0 | 0 |
| Financing Activities | -3 | -4 | -5 | -15 | -2 | 1 | -1 | 0 | 0 | -1 |
| Net Cash Flow | 7 | 3 | 30 | -6 | 26 | 7 | 2 | 1 | 0 | 0 |
3B BlackBio DX Shareholding Pattern Screener
See 3B BlackBio DX shareholding pattern with promoter, FII, and DII holdings.
Check 3B BlackBio DX promoter holding and ownership changes for 3BBLACKBIO on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Feb | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 41.28% | 41.28% | 41.28% | 41.28% | 41.29% | 41.29% | 41.29% | 41.29% |
| FII Holding | 2.49% | 2.70% | 2.64% | 2.57% | 2.97% | 2.97% | 3.28% | 3.27% |
| DII Holding | 1.60% | 1.76% | 1.82% | 1.88% | 1.89% | 1.89% | 1.96% | 1.96% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 43.31% | 43.17% | 43.53% | 38.09% | 41.94% | 41.94% | 42.22% | 42.41% |
| Other Holding | 11.32% | 11.09% | 10.73% | 16.19% | 11.92% | 11.92% | 11.26% | 11.07% |
| Shareholder Count | 10,345 | 10,619 | 10,709 | 10,507 | 9,753 | 9,753 | 9,399 | 9,586 |
3B BlackBio DX Share Dividend Screener - Share Yield Analysis
Check 3B BlackBio DX dividend history with payout and yield data.
View 3B BlackBio DX dividend details including ex-dates and amounts for 3BBLACKBIO stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹4.00 | 0.25% |
| 2024-March | ₹3.00 | 0.19% |
| 2023-March | ₹2.50 | 0.32% |
| 2022-March | ₹10.50 | 2.62% |
| 2021-March | ₹9.00 | 2.64% |
| 2020-March | ₹0.70 | 0.25% |
| 2019-March | ₹0.50 | 0.69% |
| 2018-March | ₹0.50 | 0.66% |
| 2017-March | ₹0.30 | 0.22% |
3B BlackBio DX Stock Index Membership
See which indices include 3B BlackBio DX stock.
Check 3BBLACKBIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
3B BlackBio DX Market Events Screener - Corporate Actions
Get 3B BlackBio DX corporate actions including splits, bonuses, and buybacks.
Check 3B BlackBio DX stock events that may affect 3BBLACKBIO share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 4.00 /share | -29.01% | ||
| Dividend | ₹ 1.00 /share | 16.71% | ||
| Dividend | ₹ 8.00 /share | 16.71% | ||
| Dividend | ₹ 2.50 /share | 3.50% | ||
| Dividend | ₹ 2.50 /share | 87.10% | ||
| Annual General Meeting | NA | -4.62% | ||
| Dividend | ₹ 3.00 /share | 79.92% | ||
| Annual General Meeting | NA | -8.48% | ||
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | -2.84% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 0.77% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 3.22% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 15.56% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -6.07% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -3.07% |
| 2023-11-16 | 2023-11-16 | Change Of Name | NA | 0.00% |
3B BlackBio DX Competitors Screener - Peer Comparison
Screen 3BBLACKBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 23,435 | 45.08 | 2,555 | 11.28% | 492 | 43.51 |
| Vijaya Diagnostic Centre | 10,150 | 67.35 | 700 | 23.06% | 144 | 49.38 |
| Metropolis Healthcare | 10,094 | 60.71 | 1,346 | 10.64% | 146 | 52.68 |
| Thyrocare Technologies | 6,416 | 47.08 | 702 | 20.80% | 91 | 38.76 |
| Nephrocare Health Services | 5,747 | 80.98 | 770 | 33.97% | 67 | 69.85 |
| Krsnaa Diagnostics | 2,169 | 27.26 | 743 | 16.70% | 78 | 34.08 |
| Suraksha Diagnostic | 1,485 | 45.82 | 256 | 15.11% | 31 | 60.68 |
| One Global Service Provider | 1,466 | 31.90 | 148 | 134.60% | 19 | 73.28 |
| 3B BlackBio DX | 1,368 | 24.24 | 112 | 28.72% | 48 | 50.92 |
| Sastasundar Ventures | 939 | 31.81 | 1,171 | -18.47% | -134 | 45.34 |
3B BlackBio DX Company Announcements - News Screener
Screen 3BBLACKBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-02-12 | Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025 | View |
| 2026-02-12 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2026-01-30 | Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended On 31St December 2025. | View |
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-26 | Closure of Trading Window | View |
| 2025-12-24 | Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations 2011 | View |
| 2025-12-24 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-20 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-12-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-15 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-29 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-20 | Vigilance Awareness Week 2025 | View |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |